Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.05+0.03 (+3.43%)
Close on Nov 18, 2026Market cap $178.87MP/E –Yield –
Cabaletta Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cabaletta Bio's free cash flow for the twelve months ending Jun 30, 2026 was -$154.21M. For fiscal 2025 it was -$132.31M. The highest annual figure on record is -$16.74M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$132.31M | – |
| FY2024 | Dec 31, 2024 | -$90.43M | – |
| FY2023 | Dec 31, 2023 | -$54.24M | – |
| FY2022 | Dec 31, 2022 | -$48.83M | – |
| FY2021 | Dec 31, 2021 | -$35.28M | – |
| FY2020 | Dec 31, 2020 | -$27.41M | – |
| FY2019 | Dec 31, 2019 | -$16.74M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$41.51M | – |
| Q1 FY2026 | Mar 31, 2026 | -$42.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$35.55M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$31.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$23.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.58M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$24.80M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.63M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.95M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.96M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.97M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.77M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.40M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.19M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.66M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.16M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.16M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.12M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.45M | – |
See a number that looks wrong?